Back
Speaker illustration

Mr Md Elias Al-Mamun

Tohoku University Graduate School of Medicine, Sendai (Japan)

Presentations

Rivaroxaban prevents the development of chronic thromboembolic pulmonary hypertension in mice- Novel beneficial effects of the FXa inhibitor-

Event: ESC Congress 2017

Topic: Treatment of hypertension

Session: What is new in venous thromboembolism?

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources